In parallel design studies involving 244 haemodialysis patients with treatment duration of up to 54 weeks and 97 peritoneal dialysis patients with treatment duration of 12 weeks, the most frequently occurring (≥ 5% of patients) undesirable effects possibly or probably related to Renagel were all in the gastrointestinal disorders system organ class.